Peter Evan Harwin
Director; Director, 10% Owner · 14 filings · Latest: Sep 9, 2026
Apogee Therapeutics, Inc.
Cogent Biosciences, Inc.
CRESCENT BIOPHARMA, INC.
Damora Therapeutics, Inc.
Galecto, Inc.
Jade Biosciences, Inc.
Korsana Biosciences, Inc.
Oruka Therapeutics, Inc.
Spyre Therapeutics, Inc.
Zenas BioPharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | Peter Evan Harwin | Director | Aug 7, 2026 | Option Exercise | $23.60 | 42,208 | $996.0K | 340,855 | |
CBIO | Peter Evan Harwin | Director, 10% Owner | Jul 16, 2026 | Purchase | $14.50 | 853,450 | $12.4M | 3,601,316 | |
ORKA | Peter Evan Harwin | Director, 10% Owner | Jul 1, 2026 | Sale | $84.43 | 3,553,410 | $300.0M | 1,131,954 | |
SYRE | Peter Evan Harwin | Director | Jun 23, 2026 | Sale | $85.31 | 4,684,781 | $399.7M | 0 | |
ZBIO | Peter Evan Harwin | Director | Mar 31, 2026 | Purchase | $20.00 | 150,000 | $3.0M | 2,359,025 | |
GLTO | Peter Evan Harwin | Director, 10% Owner | Feb 9, 2026 | Option Exercise | $0.00 | 8,713,000 | — | 2,904,000 | |
APGE | Peter Evan Harwin | Director | Jan 22, 2026 | Sale | $76.30 | 1,750,000 | $133.5M | 298,647 |